Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
GENERAL ATLANTIC, L.P. (CIK 1017645) reported $2.91B across 12 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: LFTO ($608.1M, 20.92%), DLO ($606.3M, 20.86%), CHYM ($435.4M, 14.98%), ALKT ($351.1M, 12.08%), XP ($334.4M, 11.50%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | LFTO | LIFTOFF MOBILE | $608.1M | 20.92% | 25.3M | New |
| 2 | DLO | DLOCAL | $606.3M | 20.86% | 46.7M | Hold |
| 3 | CHYM | CHIME | $435.4M | 14.98% | 21.3M | Hold |
| 4 | ALKT | ALKAMI | $351.1M | 12.08% | 19.4M | Added |
| 5 | XP | XP, INC | $334.4M | 11.50% | 20.6M | Hold |
| 6 | PHVS | PHARVARIS | $226.5M | 7.79% | 6.6M | Trimmed |
| 7 | SPTX | SEAPORT THERAPEUTICS | $132.5M | 4.56% | 6.1M | New |
| 8 | NRIX | NURIX THERAPEUTICS | $73.6M | 2.53% | 3.0M | Trimmed |
| 9 | RVMD | REVOLUTION MEDICINES | $67.0M | 2.31% | 357,791 | Trimmed |
| 10 | PBLS | PARABILIS MEDICINES | $42.1M | 1.45% | 1.5M | New |
| 11 | RSKD | RISKIFIED | $26.8M | 0.92% | 5.3M | Hold |
| 12 | GROV | GROVE COLLABORATIVE | $3.1M | 0.11% | 2.5M | Hold |
| 13 | CNTA | CENTESSA PHARMACEUTICALS | $0 | 0.00% | 0 | Exited |
| 14 | EWCZ | EUROPEAN WAX CENTER | $0 | 0.00% | 0 | Exited |
| 15 | BULL | WEBULL | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-06-30